Alice Lione – Pagina 9 – AMD

Alice Lione

Giugno 17, 2024 Alice Lione

Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study

Napoli R, Nicolucci A, Larosa M, et al.
Diabetes Obes Metab. Pub. online 10 Jun 2024.

Leggi

Giugno 17, 2024 Alice Lione

Data-driven phenotyping of presymptomatic type 1 diabetes using longitudinal autoantibody profiles

Ghalwash M, Anand V, Ng K, et al.
Diabetes Care. Pub. online 11 Jun 2024.

Leggi

Giugno 17, 2024 Alice Lione

Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial

Kim NH, Moon JS, Lee YH, et al.
Diabetes Obes Metab. Pub. online 11 Jun 2024.

Leggi

Giugno 17, 2024 Alice Lione

Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective

Del Prato S, Giorgino F, Szafranski K, Poon Y
Diabetes Obes Metab. Pub. online 10 Jun 2024.

Leggi

Giugno 17, 2024 Alice Lione

How do lifestyle factors modify the association between genetic predisposition and obesity-related phenotypes? A 4-way decomposition analysis using UK Biobank

Zhang M, Ward J, Strawbridge RJ, et al.
BMC Med. Pub. online 10 Jun 2024.

Leggi

Giugno 17, 2024 Alice Lione

Key results from observational studies and real-world evidence of sodium-glucose cotransporter-2 inhibitor effectiveness and safety in reducing cardio-renal risk

Nyström T
Diabetes Obes Metab. Pub. online 10 Jun 2024.

Leggi

Giugno 13, 2024 Alice Lione

NOVITA’ AMD DIGITAL NETWORK – OCCHIO AL TRIAL

Carissimi Soci, l'offerta formativa AMD digital network si arricchisce con una nuova opportunità per tutti i Soci: "Occhio al trial". In abbinamento alle ormai collaudate dirette scientific talk, è stato ideato questo nuovo spazio di approfondimento scientifico che ci consentirà di analizzare con brevi videopillole i più recenti studi in ambito diabete. Una formula…

Leggi

Giugno 13, 2024 Alice Lione

A phase 2 randomized trial of survodutide in MASH and fibrosis

Sanyal AJ, Bedossa P, Fraessdorf M, et al.
N Engl J Med. Pub. online 7 Jun 2024.

Leggi

Giugno 13, 2024 Alice Lione

Partial clinical remission of type 1 diabetes in Swedish children – a longitudinal study from the Swedish National Quality Register (SWEDIABKIDS) and the Better Diabetes Diagnosis (BDD) study

Fureman AL, Bladh M, Carlsson A, et al.
Diabetes Technol Ther. Pub. online 6 Jun 2024.

Leggi

Giugno 13, 2024 Alice Lione

Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): study protocol of a phase 2 double-blinded randomised placebo-controlled trial

Frampton R, Snaith JR, Hocking S, et al.
Diabet Med. Pub. online 9 Jun 2024.

Leggi